Biotechnology · Healthcare
Board Member
2023-09-12–present
Board Member
Calidi Biotherapeutics, Inc. (CLDI)Equibles does not estimate personal net worth.
Get an email with a short summary when Calidi Biotherapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get CLDI alertsHeehyoung Lee is recorded as Board Member at Calidi Biotherapeutics, Inc. (CLDI) since September 12, 2023. Calidi Biotherapeutics, Inc. reported in an 8-K filed October 16, 2023 that Heehyoung Lee resigned as positions on the committees of the Board, effective October 10, 2023. Calidi Biotherapeutics, Inc. reported in an 8-K filed September 19, 2023 that Heehyoung Lee was appointed Class I director, effective September 12, 2023. Calidi Biotherapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Calidi Biotherapeutics, Inc. includes Eric Poma, Ph.D. (CEO and Board Member), Thomas A. Vecchiolla (CEO and Chairman), James Schoeneck (Chairman and Board Member) and 7 others.
“On October 10, 2023, the Company announced the resignation of Dr. Heehyoung Lee, including all her positions on the committees of the Board, effective immediately.”
“George Ng, Heehyoung Lee and Alfonso Zulueta serve as the Class I directors;”
2023-09-12–present
2023-09-12–2023-10-10
Biotechnology · Healthcare
Board Member
2023-09-12–present